Asif Ali, Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX), sold 46,203 shares at $83.13 ($3.8M) on 2026-01-27, disclosed to the SEC on 2026-01-27.
Seasonal sale ($3.8M) by Chief Financial Officer — this insider has traded PTGX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.13 | 28,000 | $2.3M | 60.6% |
| 2 | $83.14 | 18,203 | $1.5M | 39.4% |
| Total | $83.13 avg | 46,203 | $3.8M | 100% |
| Filing → |
| PTGX | SELL | 2026-03-27 | $2.6M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $708K | — | Filing → |
| PTGX | SELL | 2025-04-23 | $81K | — | Filing → |